ESR1 and breast carcinoma: Mutations in the PIK3CA gene, encoding the p110α catalytic subunit, have been reported in ~30% of breast cancers (mainly estrogen receptor positive; ER+), and many other cancer types (including ovarian, urological, neural and brain, lung, colorectal and pancreatic) [101,102].